Methods and compositions for selective regulation of protein expression
US-2024102042-A1 · Mar 28, 2024 · US
US10870860B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10870860-B2 |
| Application number | US-201816194706-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 19, 2018 |
| Priority date | Mar 13, 2012 |
| Publication date | Dec 22, 2020 |
| Grant date | Dec 22, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A nuclear maize gene is mutated to result in dominant male sterility. Two mutants are provided which impact signal peptide processing. Restoration constructs and methods are provided for use of the dominant male-sterile mutants in producing hybrid seed for male-sterile hybrid plants. Other signal-peptide modifications are provided. Orthologs of the wild type or mutated gene in various species are provided.
Opening claim text (preview).
The invention claimed is: 1. A DNA construct comprising an isolated regulatory region of a maize Ms44 gene, wherein the Ms44 regulatory region is operably-linked to a heterologous polynucleotide of interest, wherein the Ms44 regulatory region initiates transcription of the heterologous polynucleotide of interest in a plant cell. 2. The DNA construct of claim 1 , wherein the Ms44 regulatory region initiates transcription in a plant cell in a male-tissue preferred manner. 3. The DNA construct of claim 1 , wherein the Ms44 regulatory region comprises the regulatory region within each of SEQ ID NO: 9 or 13. 4. The DNA construct of claim 1 , wherein the heterologous polynucleotide of interest encodes a marker. 5. The DNA construct of claim 1 , wherein the heterologous polynucleotide of interest encodes a gene product that confers drought tolerance, cold tolerance, herbicide tolerance, pathogen resistance, or insect resistance to the plant. 6. The DNA construct of claim 1 , wherein the Ms44 regulatory region initiates transcription of the heterologous polynucleotide of interest in a monocot plant cell. 7. The DNA construct of claim 6 , wherein the Ms44 regulatory region initiates transcription of the heterologous polynucleotide of interest in a maize plant cell. 8. The DNA construct of claim 1 , wherein the Ms44 regulatory region initiates transcription of the heterologous polynucleotide of interest in a dicot plant cell. 9. A vector or expression cassette, each comprising the DNA construct of claim 1 . 10. A plant cell comprising the DNA construct of claim 1 . 11. The plant cell of claim 10 , wherein the plant cell is a monocot plant cell. 12. The plant cell of claim 10 , wherein the plant cell is a dicot plant cell.
Genetically Modified [GMO] plants, e.g. transgenic plants · CPC title
Male sterility · CPC title
for stress resistance, e.g. heavy metal resistance · CPC title
Male-specific, e.g. anther, tapetum, pollen · CPC title
Transit peptides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.